SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,285,000 | -88.8% | 19,600 | -89.2% | 0.00% | -90.0% |
Q1 2021 | $11,506,000 | -42.2% | 181,440 | +27.0% | 0.02% | -37.5% |
Q4 2020 | $19,901,000 | +13.6% | 142,822 | -2.4% | 0.03% | +6.7% |
Q3 2020 | $17,524,000 | +19.8% | 146,337 | +42.9% | 0.03% | +11.1% |
Q2 2020 | $14,623,000 | -31.3% | 102,430 | -52.9% | 0.03% | +28.6% |
Q1 2020 | $21,292,000 | +145.2% | 217,664 | +188.1% | 0.02% | +50.0% |
Q4 2019 | $8,685,000 | +118.4% | 75,551 | +31.3% | 0.01% | +100.0% |
Q3 2019 | $3,976,000 | – | 57,551 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |